| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/26/2012 | WO2012100172A2 Methods and compositions for the specific inhibition of hif-1a by double stranded rna |
| 07/26/2012 | WO2012100083A2 Human induced neuronal cells |
| 07/26/2012 | WO2012100017A2 Antiretroviral cyclonucleoside compositions and methods and articles of manufacture therewith |
| 07/26/2012 | WO2012099973A2 Compositions and methods for treating cancer |
| 07/26/2012 | WO2012099375A2 P47phox or p67phox-targeting therapeutic agent for stress disorders, and method for screening for same |
| 07/26/2012 | WO2012098397A1 Combination therapy for cancer |
| 07/26/2012 | WO2012098367A1 Delivery of a selectively replicating herpes simplex viral vector to the brain by convection- enhanced delivery (ced) |
| 07/26/2012 | US20120190629 Light-receiving channel rhodopsin having improved expression efficiency |
| 07/26/2012 | US20120189537 Nitrile derivatives and their pharmaceutical use and compositions |
| 07/26/2012 | DE102010036997A1 LOV-Domänen Protein zur photosensiblen Desfunktionalisierung LOV domain protein for photosensitive Desfunktionalisierung |
| 07/26/2012 | CA2824997A1 Compositions and methods for treating cancer |
| 07/26/2012 | CA2824689A1 Combination therapy for cancer |
| 07/25/2012 | EP2479276A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 07/25/2012 | EP2479275A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 07/25/2012 | EP2479262A1 Improved modalities for the treatment of degenerative diseases of the retina |
| 07/25/2012 | EP2478913A1 Synthetic HLA binding peptide analogues and uses thereof |
| 07/25/2012 | EP2477499A1 Oncolytic vaccinia virus combination cancer therapy |
| 07/25/2012 | EP1594977B1 Reversible attachment of a membrane active polymer to a polynucleotide |
| 07/25/2012 | CN202342670U Cell culture device implanted in body |
| 07/25/2012 | CN1653179B Cartilage regeneration using chondrocyte and TGF-beta |
| 07/25/2012 | CN102612560A Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1 |
| 07/25/2012 | CN102608333A Tuberculosis diagnostic composition and application thereof |
| 07/25/2012 | CN102604992A Method for constructing recombinant adenovirus by utilizing TRAIL and HN genes as well as recombinant adenovirus and application |
| 07/25/2012 | CN102604979A Nucleotide sequence, fusion protein coded by nucleotide sequence, Mycobacterium tuberculosis vaccine prepared based on nucleotide sequence and preparation method of Mycobacterium tuberculosis vaccine |
| 07/25/2012 | CN102604969A Enterovirus 71 cDNA (complementary deoxyribose nucleic acid) infectious clone as well as construction method and application of enterovirus 71 cDNA infectious clone |
| 07/25/2012 | CN102604957A Stabilized immunomodulatory oligonucleotides |
| 07/25/2012 | CN102604952A miRNA molecule and application thereof |
| 07/25/2012 | CN102604951A Compositions and methods to treat muscular & cardiovascular disorders |
| 07/25/2012 | CN102604950A siRNA (small interference ribonucleic acid) for inhibiting DAAO (D amino acid oxidase) gene expression and medical application thereof |
| 07/25/2012 | CN102604949A Anaerobic tissue selective gene expression method driven by alcohol dehydrogenase promoter and application thereof |
| 07/25/2012 | CN102604946A Small interfering ribonucleic acid (siRNA) for inhibiting tumor metastasis and application thereof |
| 07/25/2012 | CN102604938A RNA (ribonucleic acid) interference target points for inducing hepatocellular injury |
| 07/25/2012 | CN102604128A Preparation method for gelatin nanosphere |
| 07/25/2012 | CN102603898A Fowl adenovirus group I immunity related fusion protein as well as encoding gene and application thereof |
| 07/25/2012 | CN102603893A Method of providing disease-specific binding molecules and targets |
| 07/25/2012 | CN102603885A Alexin and application thereof to preparation of antibacterial medicament |
| 07/25/2012 | CN102600482A Applications of ssc-miR-374b-5p in preparation of drugs for reducing fat deposition and/or resisting fat-related diseases |
| 07/25/2012 | CN102600481A Adenovirus (rAdV)/Japanese encephalitis virus (JEV) replicon embedding carrier hog cholera vaccine and application of rAdV/ JEV replicon embedding carrier hog cholera vaccine |
| 07/25/2012 | CN102600480A Rnai modulation of rsv and therapeutic uses thereof |
| 07/25/2012 | CN102600479A Cryptosporidium andersoni nucleic acid vaccine with cross protection and preparation method of vaccine |
| 07/25/2012 | CN102600474A Application of polyethylene glycol-polylactic-co-glycolic acid-poly-L-lysine block polymer in delivery drugs or genes |
| 07/25/2012 | CN102600471A Target spot for treating septicemia |
| 07/25/2012 | CN102600080A Enzymatic type cleavable PEGylation ( polyethylene glycol) lipid material |
| 07/25/2012 | CN102220335B Guanine-rich nucleic acid aptamer and application thereof |
| 07/25/2012 | CN102168074B Recombinant adenovirus and application thereof |
| 07/25/2012 | CN102000346B Nanometer nucleic acid guide medicine, and preparation method and application thereof |
| 07/25/2012 | CN101948544B FAT10 gene siRNA recombination analogue virus as well as preparation method and application thereof |
| 07/25/2012 | CN101947325B Vibrio paraheamolyticus bivalent DNA vaccine as well as preparation method and application thereof |
| 07/25/2012 | CN101942481B Construction and application of recombined lentivirus vector aiming at RNA interference of PKC gamma genes |
| 07/25/2012 | CN101921769B Recombinant adenovirus, preparation method and application thereof |
| 07/25/2012 | CN101864421B Structure and application of target programmed cell death protein 5 (PDCD5) anti-influenza virus oligonucleotide |
| 07/25/2012 | CN101820921B SiRNAs useful for inhibiting expression of tyrosinase gene, the compositions comprising the siRNAs and their uses |
| 07/25/2012 | CN101792491B Recombinant adenovirus HIV vaccine based on multipleseries epi-position and preparation method thereof |
| 07/25/2012 | CN101748122B Disturbing molecule for inhibiting expression of TM4SF4 and application thereof |
| 07/25/2012 | CN101732723B Polyethylene glycol-poly(lactic-co-glycolic acid)-polylysine nano-delivery system, preparation method and application thereof |
| 07/25/2012 | CN101492715B siRNA for suppressing human CSAG1 gene expression through RNA interference and uses of siRNA |
| 07/25/2012 | CN101492710B Uses of ZCCHC13 gene |
| 07/24/2012 | US8227570 Modified gherlin peptides |
| 07/24/2012 | US8227447 RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 07/24/2012 | US8227446 Oligodeoxynucleotide and its use to induce an immune response |
| 07/24/2012 | US8227445 Methods of treating hypertension |
| 07/24/2012 | US8227444 Compositions and methods for inhibition of VEGF |
| 07/24/2012 | US8227441 Methods to increase or decrease bone density |
| 07/24/2012 | US8227440 Use of Myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 07/24/2012 | US8227439 Treatment of metastatic tumors |
| 07/24/2012 | US8227437 Restoration of hearing loss |
| 07/24/2012 | US8227435 Electrotransfer of nucleic acid into tissue cells |
| 07/24/2012 | US8227432 Polynucleotide or complement comprising nucleic acid sequence flanked by first and second inverted repeats |
| 07/24/2012 | US8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D) |
| 07/24/2012 | US8227249 Methods and compositions for genomic modification |
| 07/24/2012 | US8227243 Settings for recombinant adenoviral-based vaccines |
| 07/24/2012 | US8227200 Methods for identifying kremen polypeptide binding partners |
| 07/24/2012 | US8226985 Surface modified nanoparticles, methods of their preparation, and uses thereof for gene and drug delivery |
| 07/24/2012 | US8226957 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences |
| 07/24/2012 | US8226935 ErbB2 and ErbB3 chimeric heteromultimer receptors |
| 07/24/2012 | CA2486252C Methods for screening for agents that modulate hepatocellular carcinoma development |
| 07/24/2012 | CA2471822C Cell-specific herpes simplex virus expression/replication vector comprising icp4 and human calponin gene promoter |
| 07/24/2012 | CA2342289C Treatment of cervical cancer |
| 07/24/2012 | CA2339411C Engraftable human neural stem cells |
| 07/24/2012 | CA2315538C Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 07/19/2012 | WO2012097261A2 Methods targeting mir-128 for regulating cholesterol/lipid metabolism |
| 07/19/2012 | WO2012097057A2 Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells |
| 07/19/2012 | WO2012097049A2 Dna repair enzyme inhibitor nanoparticles and uses thereof |
| 07/19/2012 | WO2012096545A2 Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |
| 07/19/2012 | WO2012096399A1 Particle composition and pharmaceutical composition using particle composition |
| 07/19/2012 | WO2012094905A1 Dna vaccine based on b7-1-pe40kdel exotoxin fusion gene and use thereof |
| 07/19/2012 | WO2012067866A3 Multivalent vaccine for filariasis |
| 07/19/2012 | WO2012064834A3 Methods for organ regeneration |
| 07/19/2012 | WO2012064743A3 Methods for improving heart function |
| 07/19/2012 | WO2012061537A9 Methods for treating hair loss disorders |
| 07/19/2012 | WO2012055551A3 NF-ĸB SIGNAL PATH-MANIPULATED DENDRITIC CELLS |
| 07/19/2012 | WO2012047287A9 Upregulation of opioid receptors for pain management |
| 07/19/2012 | WO2012040266A3 Gene-based adjuvants and compositions thereof to increase antibody production in response to gene-based vaccines |
| 07/19/2012 | WO2012021735A3 Pharmaceutical products from fungal strains |
| 07/19/2012 | WO2012017310A3 Protein fusion constructs possessing thrombolytic and anticoagulant properties |
| 07/19/2012 | WO2011133687A3 Methods and compositions for inhibition of beta2-adrenergic receptor degradation |
| 07/19/2012 | US20120184602 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 07/19/2012 | US20120184601 Antiviral oligonucleotides |
| 07/19/2012 | US20120184598 Polynucleotides for multivalent rna interference, compositions and methods of use thereof |
| 07/19/2012 | US20120184011 Emulsion Compositions |